The ion channel protein #PIEZO1 protects against cardiac injury during #cancer treatment with tyrosine kinase inhibitor #TKI#sunitinib, according to a new study in mice and patient-derived #endothelial cells. @StanfordMed https://t.co/m2J9qxBW5V
In this new @ScienceTM study from the lab of Dr. @Nazish_Sayed at @StanfordCVI, researchers identify a role for PIEZO1, a mechanically activated ion channel, in tyrosine kinase inhibitor-induced #cardiotoxicity and present a potential avenue for prevention.
🔗 https://t.co/aSsB8cLKDd
When life-saving cancer drugs put the heart at risk
New research from @stanfordcvi reveals how TKI sunitinib disrupts blood vessels’ ability to sense blood flow, driving hypertension & heart damage.
Read more: https://t.co/EgxxkBfegM
@Nazish_Sayed, @StanfordSurgery, @ScienceTM
Baszucki Research Day 2025 ✨
We welcomed Dr. Ulf Hedin from Karolinska Institute as our Baszucki Visiting Professor. From dinner with faculty & residents to a keynote on precision medicine, Biobank tour, & Grand Rounds on biobanking—what a week of innovation & collaboration! 🔬
Stanford researchers led by Drs. @NickLeeper78, @Nazish_Sayed, & @EriFukayaMD have developed an induced pluripotent stem cell (iPSC) line from a patient with varicose veins — paving the way for in vitro modeling of venous disease.
🔗: https://t.co/z150Boxrpl
Olmesartan may provide targeted, mutation-specific therapy for HF patients with an LMNA mutation @SeanM_Wu@Nazish_Sayed@SJovinge https://t.co/ipGtZSecMb
Yin lab is recruiting for positions at the University of Arizona, College of Medicine, Phoenix. If you’re interested in coronary microcirculation in diabetes and Heart Failure, please join us!
Researcher/Scientist - https://t.co/pewUZmX1BK
Postdoc - https://t.co/hNvQZMGAFf
🏆 Congratulations to Dr. Mary Hawn (@maryhawn) of @StanfordSurgery, who will receive the 2024 Wangensteen Scientific Forum Award at #ACSCC24 this weekend!
Learn more about Dr. Hawn's academic leadership and prolific scientific research. https://t.co/FwBa15ZDkz